4BB vs GS71: Side-by-Side Comparison
Compare 4BASEBIO UK SOCIETAS (4BB) and GSK plc (GS71) side by side: market cap GBX 8.13B vs EUR 91.51B. Financials, growth and model signals on Bullrun.
| Metric | 4BB | GS71 |
|---|---|---|
| Company | 4BASEBIO UK SOCIETAS | GSK plc |
| Country / Exchange | United Kingdom · LSE | United Kingdom · XETRA |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Drug Manufacturers - General |
| Market cap | GBX 8.13B | EUR 91.51B |
| P/E ratio | — | 13.8 |
| Dividend yield | — | 3.40% |
| Valuation model | — | 30.7% undervalued |
| Revenue (latest FY) | GBP 933.00K | GBP 32.67B |
| Revenue growth YoY | +84.4% | +4.1% |
| Net income | GBP -12.33M | GBP 6.29B |
| Gross margin | 67.5% | 72.4% |
| Diluted EPS | -0.94 | 1.39 |